CytRx Corporation is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.
CytRx Corporation’s product profile: DK049
“Preclinical data in animal models of pancreatic, ovarian and non-small cell lung cancers show superior anti-tumor effects compared to gemcitabine while using approximately one-sixth of the dose.”
CytRx Corp. operates as a biopharmaceutical research and development company specializing in oncology. It provides clinical development of aldoxorubicin oncology pipeline for the treatment of cancer. The company was founded on February 28, 1985 and is headquartered in Los Angeles, CA. [Source: MarketWatch]
Company Website: http://www.cytrx.com